ArticleOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2026
Decisional Conflict in Palliative Head and Neck Cancer Patients.
Article in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveHead and neck cancer (HNC) patients may be subject to decisional conflict (DC). However, research on DC in the palliative phase remains limited. The primary objective of this study was to assess and describe DC among patients with HNC in the palliative phase and explore the association between clinically significant DC and quality of life (QoL). STUDY
designProspective cohort study.
settingTertiary cancer center.
methodsPatients with HNC entering the palliative phase between September 2022 and March 2024 were eligible. Patients were assessed in 2 cohorts: incurable HNC and refraining from curative treatment. DC was measured using the Decisional Conflict Scale (DCS). Other measures included patient, tumor, and palliative characteristics, and the EORTC QLQ-C15-PAL for QoL.
resultsOf 104 included patients, 72 patients had incurable HNC and 32 refrained from curative treatment. Clinically significant DC (score ≥25) was observed in 47 incurable HNC patients (65.3%) and 14 patients who refrained from curative treatment (43.8%), which was a significant difference. Tumor stage I/II was significantly predictive of less DC in patients who refrained from curative treatment. Three QoL domains showed large differences for incurable HNC patients when differentiating for clinically significant DC, and 6 for those who refrained from treatment.
conclusionThis study provides valuable insights into DC among palliative HNC patients. Clinically significant DC was more common in patients with incurable HNC than those who refrained from curative treatment. These findings highlight key differences between the cohorts, underscoring the need for tailored counselling to support patient-centered care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.